Deregulation of lactate permeability using a small-molecule transporter (Lactrans-1) disturbs intracellular pH and triggers cancer cell death.

Anionophores Cancer metabolism Click-tambjamines Lactate Small molecules pH deregulation

Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 14 02 2024
revised: 05 08 2024
accepted: 05 08 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 8 8 2024
Statut: aheadofprint

Résumé

Due to the relevance of lactic acidosis in cancer, several therapeutic strategies have been developed targeting its production and/or regulation. In this matter, inhibition approaches of key proteins such as lactate dehydrogenase or monocarboxylate transporters have showed promising results, however, metabolic plasticity and tumor heterogeneity limits their efficacy. In this study, we explored the anticancer potential of a new strategy based on disturbing lactate permeability independently of monocarboxylate transporters activity using a small molecule ionophore named Lactrans-1. Derived from click-tambjamines, Lactrans-1 facilitates transmembrane lactate transportation in liposome models and reduces cancer cell viability. The results showed that Lactrans-1 triggered both apoptosis and necrosis depending on the cell line tested, displaying a synergistic effect in combination with first-line standard chemotherapeutic cisplatin. The ability of this compound to transport outward lactate anions was confirmed in A549 and HeLa cells, two cancer cell lines having distinct rates of lactate production. In addition, through cell viability reversion experiments it was possible to establish a correlation between the amount of lactate transported and the cytotoxic effect exhibited. The movement of lactate anions was accompanied with intracellular pH disturbances that included basification of lysosomes and acidification of the cytosol and mitochondria. We also observed mitochondrial swelling, increased ROS production and activation of oxidative stress signaling pathways p38-MAPK and JNK/SAPK. Our findings provide evidence that enhancement of lactate permeability is critical for cellular pH homeostasis and effective to trigger cancer cell death, suggesting that Lactrans-1 may be a promising anticancer therapy.

Identifiants

pubmed: 39117009
pii: S0006-2952(24)00452-0
doi: 10.1016/j.bcp.2024.116469
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116469

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alain Arias-Betancur (A)

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08907, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Signalling, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Integral Adult Dentistry, Research Centre for Dental Sciences (CICO), Dental School, Universidad de La Frontera, 4811230 Temuco, Chile.

Pere Fontova (P)

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08907, L'Hospitalet de Llobregat, Barcelona, Spain; Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Daniel Alonso-Carrillo (D)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Israel Carreira-Barral (I)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Janneke Duis (J)

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08907, L'Hospitalet de Llobregat, Barcelona, Spain; Avans University of Applied Science, 4818 AJ Breda, the Netherlands.

María García-Valverde (M)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Vanessa Soto-Cerrato (V)

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08907, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Signalling, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain.

Roberto Quesada (R)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain. Electronic address: rquesada@ubu.es.

Ricardo Pérez-Tomás (R)

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08907, L'Hospitalet de Llobregat, Barcelona, Spain; Molecular Signalling, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: rperez@ub.edu.

Classifications MeSH